VIVAN Life Sciences Blog
SPARC licenses Xelpros to Sun Pharma for US market
Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market.
In addition to up-front payment of USD 3 million, SPARCBSE 2.83 % will receive certain other milestone payments, both totaling to USD 16 million from Sun Pharma, Sun Pharma and SPARC said in a joint statement today.
“It is also eligible for certain defined royalties and additional milestone payments linked to the actual ..
